Production (Stage)
BioSyent Inc.
BIOYF
$8.56
$0.00740.09%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.27% | 10.83% | 13.36% | 33.13% | 37.03% |
| Total Depreciation and Amortization | 193.82% | 171.74% | -34.93% | -29.62% | -31.45% |
| Total Amortization of Deferred Charges | -89.03% | -91.67% | 387.31% | 291.48% | 350.56% |
| Total Other Non-Cash Items | 119.02% | 76.93% | -609.55% | -1,682.45% | -649.76% |
| Change in Net Operating Assets | -488.12% | 160.62% | -112.31% | -1,199.51% | 122.99% |
| Cash from Operations | -3.42% | 67.72% | 1.66% | -53.16% | 74.59% |
| Capital Expenditure | -9.33% | 11.42% | -303.49% | -126.73% | -115.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,572.56% | 332.97% | 411.77% | 63.25% | 102.40% |
| Cash from Investing | 1,623.66% | 260.20% | 343.89% | 62.69% | 101.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.45% | -5.29% | -5.24% | -5.75% | -6.60% |
| Issuance of Common Stock | 361.73% | 274.29% | -- | -- | -- |
| Repurchase of Common Stock | -14.40% | -55.75% | 16.56% | 17.47% | -37.62% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.07% | -7.10% | -5.05% | -36.76% | -102.80% |
| Other Financing Activities | 14.48% | 13.45% | 12.87% | 12.21% | 11.72% |
| Cash from Financing | -4.56% | -32.38% | 11.39% | 5.86% | -45.59% |
| Foreign Exchange rate Adjustments | 106.68% | 115.29% | -253.23% | -190.76% | -161.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 480.67% | 2,577.84% | 105.92% | -20.25% | 105.39% |